What's in CStone Pharmaceuticals's pipeline?

CStone Pharmaceuticals has 10 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 7 in Phase 1.

Which companies overlap with CStone Pharmaceuticals's portfolio?

Top competitors by shared drug class: Ascletis Pharmaceuticals Co., Ltd., Assistance Publique Hopitaux De Marseille, AstraZeneca, Biocad, Celltrion.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cstone-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

CStone Pharmaceuticals — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CStone Pharmaceuticals pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
CS1001+ Fluorouracil+Cisplatin	CS1001+ Fluorouracil+Cisplatin	phase 3	PD-L1 inhibitor + chemotherapy combination	PD-L1	Oncology
CS1001 monoclonal antibody	CS1001 monoclonal antibody	phase 3	PD-L1 inhibitor	PD-L1	Oncology
Placebo+ Fluorouracil+Cisplatin	Placebo+ Fluorouracil+Cisplatin	phase 3	Chemotherapy combination (antimetabolite + platinum agent)		Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ascletis Pharmaceuticals Co., Ltd. · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
AstraZeneca · 1 shared drug class
Biocad · 1 shared drug class
Celltrion · 1 shared drug class
Clovis Oncology, Inc. · 1 shared drug class
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. · 1 shared drug class
3D Medicines (Sichuan) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for CStone Pharmaceuticals:

Cite this brief

Drug Landscape (2026). CStone Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cstone-pharmaceuticals. Accessed 2026-06-10.